Intercept Pharmaceuticals

Intercept Pharmaceuticals Announces Pricing of Upsized $250 Million Public Offering and Concurrent Private Placement of Common Stock
Intercept Pharmaceuticals Announces Pricing of Upsized $250 Million Public Offering and Concurrent Private Placement of Common Stock
CP Wire
Intercept Pharmaceuticals
Flag link:
3 Mid-Cap Biotech Stocks That May Be Red-Hot Takeover Candidates
3 Mid-Cap Biotech Stocks That May Be Red-Hot Takeover Candidates
Motley Fool
biotech
M&A
Exelixis
Portola Pharmaceuticals
Intercept Pharmaceuticals
Flag link:
Could These 2 Small Biotechs Beat Allergan and Gilead Sciences?
Could These 2 Small Biotechs Beat Allergan and Gilead Sciences?
Motley Fool
biotech
Allergan
Gilead Sciences
Genfit
Intercept Pharmaceuticals
NASH
Flag link:
Seven $1 billion-plus drugs seen reaching market in 2016
Seven $1 billion-plus drugs seen reaching market in 2016
Yahoo/Reuters
Intercept Pharmaceuticals
Gilead Sciences
Roche
AbbVie
Merck
obeticholic acid
emtricitabine
Flag link:
2015's Worst Clinical Failures
2015's Worst Clinical Failures
Motley Fool
clinical trials
liver disease
cancer pain
Eli Lilly
Intercept Pharmaceuticals
GW Pharma
Flag link:
Intercept's much-hyped NASH drug misses the mark in Phase II
Intercept's much-hyped NASH drug misses the mark in Phase II
Fierce Biotech
Intercept Pharmaceuticals
NASH
Sumitomo Dainippon
Japan
OCA
Flag link:
5 Biotech Stocks On Deck With The FDA
5 Biotech Stocks On Deck With The FDA
Yahoo/Benzinga
FDA
Alnylam
Patisiran
Esperion Therapeutics
ETC-1002
Intercept Pharmaceuticals
obeticholic acid
Sarepta Therapeutics
eteplirsen
Tekmira
TKM-PLK1
Flag link:
4 Biotech and Pharma Stocks Projected to Rise 50% to 100%
4 Biotech and Pharma Stocks Projected to Rise 50% to 100%
24/7 Wall St
Flex Pharma
Intercept Pharmaceuticals
Intra-Cellular Therapies
SteadyMed
Flag link:
Why Intercept Might Be A Better Bet Than Biogen Right Now
Why Intercept Might Be A Better Bet Than Biogen Right Now
Yahoo/Benzinga
Intercept Pharmaceuticals
Biogen Idec
Flag link:
3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week
3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week
24/7 Wall St
Amgen
evolocumab
Biogen Idec
BIIB037
OCA
obeticholic acid
Intercept Pharmaceuticals
Flag link:
Is The Biotechnology Bubble Turning Into Mania?
Is The Biotechnology Bubble Turning Into Mania?
Forbes
biotech
Gilead Sciences
Amgen
Regeneron
Puma Biotechnology
Isis Pharmaceuticals
Pharmacyclics
Intercept Pharmaceuticals
Flag link:
3 Biotech Stocks We're Watching Closest Ahead of the JPMorgan Healthcare Conference
3 Biotech Stocks We're Watching Closest Ahead of the JPMorgan Healthcare Conference
Motley Fool
Celgene
Intercept Pharmaceuticals
Amicus Therapeutics
Flag link:
Intercept Pharmaceuticals Below $180: Mega Millions Vanish
Intercept Pharmaceuticals Below $180: Mega Millions Vanish
Forbes
Intercept Pharmaceuticals
Flag link:
The 5 Best Biotech Stocks in 2014...so far
The 5 Best Biotech Stocks in 2014...so far
Motley Fool
biotech
Intercept Pharmaceuticals
Achillion
Puma Biotechnology
PTC Therapeutics
Receptos
Flag link:
5 Huge Biotech Catalysts Right Around the Corner for Top Stocks
5 Huge Biotech Catalysts Right Around the Corner for Top Stocks
24/7 Wall St
Arrowhead Research
Gilead Sciences
Intercept Pharmaceuticals
Amgen
Vertex Pharmaceuticals
RNAi
Kyprolis
VX-661
Sovaldi
Kalydeco
Flag link:
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic
Yahoo/AccessWire
Galectin
Intercept Pharmaceuticals
NASH
Flag link:
4 Key Positive Biotech Stock Catalysts Coming Very Soon
4 Key Positive Biotech Stock Catalysts Coming Very Soon
24/7 Wall St
Amicus Therapeutics
Baxter International
Halozyme
Intercept Pharmaceuticals
Repros Therapeutics
Flag link:
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Alexion
InterMune
FDA
Acadia
Kythera
Intercept Pharmaceuticals
Merrimack Pharmaceuticals
Relypsa
MM-398
patiromer
Esbriet
ATX-101
Soliris
Flint
pimavanserin
Flag link:
Today's Top Biotech Stocks to Watch: Intercept Pharmaceuticals and VIVUS
Today's Top Biotech Stocks to Watch: Intercept Pharmaceuticals and VIVUS
Motley Fool
Vivus
Intercept Pharmaceuticals
M&A
Aspen Investments
OCA
Flag link:
8 Biotech Events To Anticipate This Year: Part One
8 Biotech Events To Anticipate This Year: Part One
Seeking Alpha
Zohydro
Zogenix
Zybrestat
Oxigene
Arikayce
Insmed
obeticholic acid
Intercept Pharmaceuticals
Flag link: